<DOC>
	<DOCNO>NCT02163837</DOCNO>
	<brief_summary>Hepatic encephalopathy responsible sleep disturbance daytime sleepiness . The purpose study assess sleep quality , quantity , sleep scheme physical activity patient suffer HE , 2 week treatment rifaximine , currently give low blood ammoniac level .</brief_summary>
	<brief_title>Effect Rifaximine Sleep Disorders Patients Suffering From Hepatic Encephalopathy</brief_title>
	<detailed_description>Hepatic encephalopathy ( HE ) complex neuropsychiatric syndrome relate chronic/acute hepatic failure . Sleep architecture disturb syndrome , patient complain mainly excessive daytime sleepiness sleep disturbance . Hypothesis explain symptom , among others , disturb melatonin metabolism . Few study conduct order study sleep disorder HE , effect treatment unknown . Recently , rifaximine , oral broad spectrum antibiotic , proved decrease ammoniac production patient HE . The purpose study assess sleep quality , quantity , sleep scheme physical activity patient suffer HE , 2 week treatment rifaximine .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<criteria>&gt; 18y hepatic encephalopathy : positive Conn score &lt; 18y pregnancy inability fulfil questionnaire acute infection unstable clinical condition bone articular disease result significant disability</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>sleep quality</keyword>
	<keyword>physical activity</keyword>
	<keyword>daytime sleepiness</keyword>
	<keyword>actigraphy</keyword>
	<keyword>quality life</keyword>
</DOC>